We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFIE
2401
DELISTED
Profire Energy, Inc
PFIE
$62.9K ﹤0.01%
44,299
-60,571
-58% -$97.8K
LANV.WS
2402
CALL
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$61K ﹤0.01%
34,090
XLI icon
2403
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
$60.9K ﹤0.01%
500
-22,900
-98% -$2.82M
REI icon
2404
Ring Energy
REI
$322M
$60.1K ﹤0.01%
+35,541
New +$65.4K
AFMD
2405
DELISTED
Affimed
AFMD
$60.1K ﹤0.01%
11,020
-107,242
-91% -$602K
LVO icon
2406
LiveOne
LVO
$66M
$59.3K ﹤0.01%
+3,776
New +$66.7K
IFRX icon
2407
InflaRx
IFRX
$256M
$58.9K ﹤0.01%
33,824
-47,995
-59% -$70.4K
WULF icon
2408
TeraWulf
WULF
$9.15B
$57.6K ﹤0.01%
12,950
-783,475
-98% -$2.11M
PLUG icon
2409
Plug Power
PLUG
$2.92B
$57.1K ﹤0.01%
24,492
+10,882
+80% +$31.2K
ICL icon
2410
ICL Group
ICL
$6.81B
$56.3K ﹤0.01%
+13,156
New +$61.9K
NAGE
2411
Niagen Bioscience
NAGE
$256M
$56.2K ﹤0.01%
+20,577
New +$68.9K
BZUN
2412
Baozun
BZUN
$144M
$55.4K ﹤0.01%
+23,684
New +$61.3K
CLOV icon
2413
Clover Health Investments
CLOV
$2.28B
$55.2K ﹤0.01%
+44,856
New +$40.3K
XBIT icon
2414
XBiotech
XBIT
$69.2M
$54.3K ﹤0.01%
10,573
-44,106
-81% -$340K
LUMN icon
2415
Lumen
LUMN
$6.53B
$54.2K ﹤0.01%
+49,300
New +$62.5K
EXFY icon
2416
Expensify
EXFY
$166M
$53.5K ﹤0.01%
+35,899
New +$56.6K
TOP icon
2417
TOP Financial Group
TOP
$1.35B
$52.9K ﹤0.01%
20,333
-5,434
-21% -$13.9K
INTC icon
2418
CALL
Intel
INTC
$466B
$52.6K ﹤0.01%
+1,700
New +$55.7K
TRUE
2419
DELISTED
TrueCar
TRUE
$51.7K ﹤0.01%
16,506
-187,353
-92% -$549K
UNH icon
2420
PUT
UnitedHealth
UNH
$382B
$50.9K ﹤0.01%
100
-149,900
-100% -$73.5M
MSAIW icon
2421
CALL
MultiSensor AI Holdings Warrant
MSAIW
$949K
$49.2K ﹤0.01%
30,000
-61,941
-67% -$2.94K
IMPP icon
2422
Imperial Petroleum
IMPP
$215M
$47.8K ﹤0.01%
+12,327
New +$45.6K
PETS icon
2423
PetMed Express
PETS
$42.5M
$46.1K ﹤0.01%
+11,373
New +$48.6K
IMUX icon
2424
Immunic
IMUX
$182M
$44K ﹤0.01%
3,962
-991
-20% -$12.3K
ACET icon
2425
Adicet Bio
ACET
$72.8M
$42.7K ﹤0.01%
+2,208
New +$59.2K

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.